Grants for Small businesses - Health

This funding opportunity supports research institutions and organizations conducting experimental studies with human participants to explore new brain stimulation techniques for treating substance use disorders.

This funding opportunity supports research projects aimed at reducing violence against women and girls and improving responses within the criminal justice system, targeting issues such as domestic violence, sexual violence, and stalking.

The Indiana Department of Health (IDOH) is offering a grant opportunity to provide intranasal naloxone kits to first responders in rural counties of Indiana. The grant, funded in part by the Substance Abuse Mental Health Services Administration (SAMHSA) under the First Responder Comprehensive Addiction and Recovery Act, aims to enhance the capacity of first responders to address opioid-related incidents. Eligible first responders include professional and volunteer firefighters, law enforcement officers, paramedics, emergency medical technicians, and other recognized volunteer organizations. Grant recipients are required to administer naloxone as needed, report usage via an online survey, and refrain from selling or distributing the naloxone doses. The grant period runs from October 2023 through September 2024, with a total funding amount of $287,500 available. Non financial aid, only Naloxone kits

This funding opportunity provides financial support for early-stage researchers to conduct small-scale studies that inform public health policies related to tobacco use and regulation.

This funding opportunity supports researchers and organizations in developing advanced tissue-engineered technologies that mimic cancer biology to improve cancer detection, treatment, and prevention.

This funding opportunity provides financial support for organizations to develop and validate digital therapeutic technologies designed to treat substance use disorders, with the goal of achieving FDA authorization.

The City of San Diego's Economic Development Department is offering a grant of $10,000 to $100,000 to nonprofit organizations that can assist small businesses in under-resourced communities, with funds to be used for capacity building expenses such as technical assistance, website creation, and event programming, with priority given to organizations with modest budgets and proposals aligning with the Economic Development Strategy.

This initiative provides financial support and mentorship to minority-owned small businesses in specific West Side neighborhoods of Chicago, helping them grow and contribute to their communities.

This grant provides funding for clinical trials investigating the safety and effectiveness of amyloid-beta antibody therapies in patients with mild cognitive impairment or dementia who also show signs of Lewy Body Dementia, with a focus on diverse and underrepresented populations.

This program provides funding to rural communities for projects that improve access to education and healthcare through advanced telecommunications technologies.

This funding opportunity supports a wide range of organizations in developing innovative treatments and testing strategies to prevent and modify epilepsy and other neurological disorders.

This funding opportunity supports researchers aiming to enhance existing breast cancer clinical studies by extending follow-up activities, improving data analysis, and maximizing the use of previously collected patient data and biospecimens.

This grant provides funding for state and community programs, as well as research initiatives, aimed at developing and promoting effective strategies to prevent and control injuries and violence, with a focus on health equity and community conditions.

This Notice informs that NIA intends to publish a Notice of Funding Opportunity (NOFO) inviting applications from mid-career investigators for mentored career enhancement awards focused on cross-disciplinary training to broaden and strengthen the investigator's capability to lead future comparative studies of the factors contributing to differences in life spans between human and nonhuman primate species. The NOFO is intended to provide support for experienced investigators with expertise in human and/or nonhuman primate (NHP) studies to do the following: 1) Augment or redirect their research program by acquiring expertise in other fields related to comparative primate research and aging 2) Develop collaborations with research fields with which they do not commonly interact This Notice is being provided to allow potential applicants sufficient time to identify potential mentors and prepare well-developed career enhancement plans. The NOFO is expected to be published in June 2024 with an anticipated application due date in November 2024. These are estimated time frames, and they may change. The NOFO is expected to utilize the K18 Career Enhancement Award activity code. It is expected that the NOFO will not allow clinical trials. Additional details of the planned NOFO are provided below.

This funding opportunity provides financial support to organizations that deliver comprehensive HIV care and essential services for women, infants, children, and youth affected by HIV in designated geographic areas.

This funding opportunity provides financial support to small businesses in the U.S. for conducting exploratory clinical trials or biomarker validation studies aimed at advancing therapies for neurological disorders.

This funding opportunity supports collaborative research consortia focused on understanding the brain-body interactions that lead to excessive alcohol use and Alcohol Use Disorder, aiming to identify biological markers for prevention and intervention.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The NOFO is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this NOFO include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; 2) screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches to identify initial screening hits; 3) hit validation, including implementation of secondary assays that are orthogonal to the primary assay, advanced cheminformatics analysis and initial medicinal chemistry inspection to prioritize the hit set, and follow-up assays to characterize mode and mechanism of action of the validated hits; 4) hit-to-lead optimization, including SAR to optimize target engagement, selectivity and to minimize chemical liabilities, ADME, PK and PD studies, and, if appropriate, in vivo modeling to test efficacy or biological effects.

This funding opportunity provides financial support for researchers to analyze existing data on late talking children, particularly focusing on underrepresented populations, to better understand their developmental trajectories and improve language outcomes.

This fellowship provides support, resources, and funding to U.S. entrepreneurs developing scalable solutions in climate, health, and equity, with a focus on historically underrepresented founders.